Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3

Retraction of ‘MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3’ by Shiming Yang et al., RSC Adv., 2018, 8, 34973–34983, DOI: 10.1039/C8RA07055E.

Detalles Bibliográficos
Autor principal: Fisher, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694355/
https://www.ncbi.nlm.nih.gov/pubmed/35427002
http://dx.doi.org/10.1039/d1ra90019f
_version_ 1784619336087896064
author Fisher, Laura
author_facet Fisher, Laura
author_sort Fisher, Laura
collection PubMed
description Retraction of ‘MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3’ by Shiming Yang et al., RSC Adv., 2018, 8, 34973–34983, DOI: 10.1039/C8RA07055E.
format Online
Article
Text
id pubmed-8694355
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-86943552022-04-13 Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3 Fisher, Laura RSC Adv Chemistry Retraction of ‘MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3’ by Shiming Yang et al., RSC Adv., 2018, 8, 34973–34983, DOI: 10.1039/C8RA07055E. The Royal Society of Chemistry 2021-01-20 /pmc/articles/PMC8694355/ /pubmed/35427002 http://dx.doi.org/10.1039/d1ra90019f Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Fisher, Laura
Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3
title Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3
title_full Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3
title_fullStr Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3
title_full_unstemmed Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3
title_short Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3
title_sort retraction: mir-182-5p and mir-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting rnd3
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694355/
https://www.ncbi.nlm.nih.gov/pubmed/35427002
http://dx.doi.org/10.1039/d1ra90019f
work_keys_str_mv AT fisherlaura retractionmir1825pandmir965pincreasedhepatocellularcarcinomacellmobilityproliferationandcisplatinresistancepartiallybytargetingrnd3

Ejemplares similares